West Pharmaceutical Services, Inc. Peer Comparison

Metric Value Ranking
Market Cap $14.6 Billion 5/12 BDX
$57.1B		 RMD
$31.3B		 COO
$15.9B		 BAX
$14.8B		 WST
$14.6B		 HOLX
$12.9B		 RGEN
$7.3B		 TFX
$5.8B		 MMSI
$5.4B		 ICUI
$3.4B		 HAE
$2.9B		 EMBC
$659.2M
Gross Margin 37% 10/12 COO
68%		 EMBC
60%		 RMD
59%		 HOLX
57%		 HAE
56%		 TFX
55%		 RGEN
50%		 MMSI
49%		 BDX
43%		 WST
37%		 ICUI
36%		 BAX
35%
Profit Margin 17% 3/12 RMD
27%		 HOLX
20%		 WST
17%		 COO
11%		 HAE
11%		 MMSI
8%		 BDX
6%		 EMBC
0%		 ICUI
-4%		 TFX
-17%		 BAX
-19%		 RGEN
-20%
EBITDA margin 27% 3/12 HOLX
34%		 RMD
28%		 WST
27%		 RGEN
20%		 COO
19%		 HAE
17%		 EMBC
15%		 ICUI
14%		 MMSI
10%		 BDX
9%		 TFX
-5%		 BAX
-6%
Quarterly Revenue $748.8 Million 7/12 BDX
$5.2B		 BAX
$2.8B		 RMD
$1.3B		 HOLX
$1.0B		 COO
$964.7M		 TFX
$795.4M		 WST
$748.8M		 ICUI
$629.8M		 MMSI
$355.2M		 HAE
$348.5M		 EMBC
$261.9M		 RGEN
$167.5M
Quarterly Earnings $130.1 Million 4/12 RMD
$344.6M 		BDX
$303.0M 		HOLX
$201.0M 		WST
$130.1M 		COO
$104.3M 		HAE
$37.5M 		MMSI
$27.9M 		EMBC
-$700,000 		ICUI
-$23.8M 		RGEN
-$33.9M 		TFX
-$136.7M 		BAX
-$512.0M
Quarterly Free Cash Flow $85.2 Million 7/12 BDX
$588.0M 		BAX
$351.0M 		RMD
$289.7M 		HOLX
$172.5M 		TFX
$170.4M 		COO
$101.2M 		WST
$85.2M 		HAE
$35.2M 		ICUI
$13.6M 		MMSI
-$0 		RGEN
-$0 		EMBC
-$6.8M
Trailing 4 Quarters Revenue $2.9 Billion 7/12 BDX
$20.6B		 BAX
$12.9B		 RMD
$4.9B		 HOLX
$4.0B		 COO
$3.9B		 TFX
$3.0B		 WST
$2.9B		 ICUI
$2.4B		 HAE
$1.4B		 MMSI
$1.4B		 EMBC
$1.1B		 RGEN
$614.2M
Trailing 4 Quarters Earnings $492.7 Million 4/12 BDX
$5.2B 		BAX
$2.8B 		RMD
$1.3B 		HOLX
$1.0B 		COO
$964.7M 		TFX
$795.4M 		WST
$748.8M 		ICUI
$629.8M 		MMSI
$355.2M 		HAE
$348.5M 		EMBC
$261.9M 		RGEN
$167.5M
Quarterly Earnings Growth -5% 6/12 RMD
65% 		COO
28% 		HAE
20% 		BDX
8% 		MMSI
1% 		WST
-5% 		HOLX
-18% 		RGEN
-33% 		ICUI
-39% 		EMBC
-103% 		BAX
-309% 		TFX
-539%
Annual Earnings Growth -21% 8/12 BDX
135% 		EMBC
51% 		HOLX
44% 		RMD
44% 		COO
24% 		HAE
23% 		MMSI
14% 		WST
-21% 		TFX
-84% 		BAX
-108% 		RGEN
-135% 		ICUI
-2677%
Quarterly Revenue Growth 2% 9/12 HOLX
268% 		BDX
10% 		RMD
10% 		MMSI
9% 		RGEN
8% 		ICUI
7% 		HAE
4% 		TFX
3% 		WST
2% 		COO
0% 		EMBC
-6% 		BAX
-29%
Annual Revenue Growth -3% 11/12 COO
41% 		HOLX
30% 		RMD
22% 		MMSI
7% 		HAE
6% 		ICUI
6% 		RGEN
6% 		BDX
3% 		TFX
1% 		EMBC
-1% 		WST
-3% 		BAX
-14%
Cash On Hand $484.6 Million 5/12 HOLX
$1.8B 		BAX
$1.8B 		BDX
$711.0M 		RMD
$521.9M 		WST
$484.6M 		MMSI
$376.7M 		HAE
$320.8M 		ICUI
$308.6M 		TFX
$290.2M 		EMBC
$210.0M 		COO
$100.9M 		RGEN
-$0
Short Term Debt $17.9 Million 8/12 BAX
$2.8B 		BDX
$1.3B 		TFX
$100.0M 		HOLX
$53.4M 		ICUI
$51.0M 		COO
$49.7M 		RMD
$37.7M 		WST
$17.9M 		EMBC
$12.9M 		MMSI
$10.3M 		HAE
$5.1M 		RGEN
-$0
Long Term Debt $284.4 Million 10/12 BDX
$17.4B		 BAX
$10.6B		 COO
$2.5B		 TFX
$1.7B		 EMBC
$1.6B		 ICUI
$1.5B		 HAE
$1.2B		 RMD
$802.0M		 MMSI
$799.8M		 WST
$284.4M		 HOLX
$22.2M		 RGEN
$0
PE 29.62 5/12 TFX
83.03		 MMSI
44.61		 COO
38.28		 BDX
32.64		 WST
29.62		 RMD
25.04		 HAE
22.08		 HOLX
17.36		 EMBC
11.47		 BAX
-1.00		 ICUI
-1.00		 RGEN
-1.00
PS 5.05 3/12 RGEN
11.89		 RMD
6.35		 WST
5.05		 COO
4.05		 MMSI
3.96		 HOLX
3.20		 BDX
2.76		 HAE
2.09		 TFX
1.90		 ICUI
1.43		 BAX
1.15		 EMBC
0.60
PB 5.44 2/12 RMD
5.95		 WST
5.44		 MMSI
3.89		 RGEN
3.62		 HAE
3.17		 HOLX
2.71		 BDX
2.26		 BAX
2.11		 COO
1.96		 ICUI
1.74		 TFX
1.35		 EMBC
0.00
PC 30.12 4/12 COO
157.59		 BDX
80.25		 RMD
59.91		 WST
30.12		 TFX
19.94		 MMSI
14.25		 ICUI
11.06		 HAE
8.95		 BAX
8.40		 HOLX
7.25		 EMBC
3.14		 RGEN
-1.00
Liabilities to Equity 0.36 9/12 BAX
2.69		 HAE
1.79		 BDX
1.17		 ICUI
1.14		 HOLX
0.83		 MMSI
0.75		 TFX
0.66		 COO
0.50		 WST
0.36		 RMD
0.36		 EMBC
0.00		 RGEN
-1.00
ROA 0.14 2/12 RMD
17% 		WST
14% 		HOLX
9% 		HAE
5% 		MMSI
5% 		EMBC
5% 		BDX
3% 		COO
3% 		TFX
1% 		BAX
-3% 		ICUI
-3% 		RGEN
-100%
ROE 0.18 2/12 RMD
24% 		WST
18% 		HOLX
16% 		HAE
14% 		MMSI
9% 		BDX
7% 		COO
5% 		TFX
2% 		RGEN
-1% 		ICUI
-6% 		EMBC
-7% 		BAX
-9%
Current Ratio 3.79 1/12 WST
3.79		 RMD
3.78		 COO
2.98		 TFX
2.52		 MMSI
2.33		 HOLX
2.21		 ICUI
1.88		 BDX
1.86		 HAE
1.56		 BAX
1.37		 EMBC
0.60		 RGEN
0.00
Quick Ratio 0.50 1/12 TFX
83.03		 MMSI
44.61		 COO
38.28		 BDX
32.64		 WST
29.62		 RMD
25.04		 HAE
22.08		 HOLX
17.36		 EMBC
11.47		 BAX
-1.00		 ICUI
-1.00		 RGEN
-1.00
Long Term Debt to Equity 0.11 9/12 BAX}
1.52		 HAE}
1.35		 ICUI}
0.78		 BDX}
0.69		 MMSI}
0.58		 TFX}
0.39		 COO}
0.31		 RMD}
0.15		 WST}
0.11		 HOLX}
0.00		 RGEN}
0.00		 EMBC}
-2.03
Debt to Equity 0.11 9/12 BAX
1.93		 HAE
1.35		 ICUI
0.81		 BDX
0.74		 MMSI
0.59		 TFX
0.41		 COO
0.31		 RMD
0.16		 WST
0.11		 HOLX
0.01		 RGEN
0.00		 EMBC
-2.05
Burn Rate -4.24 11/12 MMSI
56.84		 HAE
25.53		 COO
12.98		 EMBC
3.16		 ICUI
3.15		 TFX
1.27		 BAX
1.07		 BDX
0.98		 RGEN
0.00		 RMD
-1.72		 WST
-4.24		 HOLX
-9.54
Cash to Cap 0.03 8/12 EMBC
0.32		 HOLX
0.14		 BAX
0.12		 HAE
0.11		 ICUI
0.09		 MMSI
0.07		 TFX
0.05		 WST
0.03		 RMD
0.02		 BDX
0.01		 COO
0.01		 RGEN
0.00
CCR 0.65 7/12 EMBC
9.71		 BDX
1.94		 COO
0.97		 HAE
0.94		 HOLX
0.86		 RMD
0.84		 WST
0.65		 RGEN
0.00		 ICUI
-0.57		 BAX
-0.69		 TFX
-1.25		 MMSI
EV to EBITDA 70.38 6/12 RGEN}
216.51		 BDX}
165.79		 MMSI}
158.68		 COO}
100.77		 RMD}
87.21		 WST}
70.38		 HAE}
63.97		 ICUI}
53.62		 EMBC}
51.83		 HOLX}
31.76		 BAX}
-150.59		 TFX}
-199.54
EV to Revenue 4.98 3/12 RGEN
11.89		 RMD
6.41		 WST
4.98		 COO
4.67		 MMSI
4.28		 BDX
3.64		 HOLX
2.77		 HAE
2.75		 TFX
2.38		 BAX
2.06		 ICUI
1.97		 EMBC
1.83

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions